Equity

3 Months Ended

Mar. 31, 2012

Equity

Stockholders' Equity Note Disclosure [Text Block]

NOTE 5 – STOCKHOLDERS’ DEFICIENCY

The Company has authorized an unlimited number of shares of preferred stock, no par value, with such rights, preferences and designation and to be issued in such series as determined by the Board of Directors. No shares of preferred stock are issued and outstanding at March 31, 2012 or June 30, 2011.

The Company has authorized an unlimited number of shares of no par value common stock, of which 4,346,760, and 4,346,760 shares are outstanding at March 31, 2012 and  June 30, 2011, respectively.

In the fiscal year ended June 30, 2011, the Company issued 89,080 shares in the reverse acquisition as described in Note 1.

In July 2010, the Company sold 240,000 units of its common stock for an aggregate consideration of $12,000.  Each unit consisted of 1 share of common stock and 10 warrants to acquire a share of the Company’s common stock at an exercise price of $0.07 per share with expiration date on December 31, 2014 (2,400,000 warrants in aggregate).  As of  March 31, 2012 and June 30, 2011, the Company has outstanding and exerciseable warrants of 2,400,000 resulting from this transaction.

In March 2011, the Company sold 11,000 shares of its common stock for cash for net proceeds of $1,100.

The officer and director contributed $7,200 in cash to the Company in March, 2011, and $60 in the quarter ended December 31, 2011.